Amwell® to Participate in Upcoming Investor Conference

Amwell® (NYSE: AMWL), a leading provider in technology-enabled healthcare, has announced that Mark Hirschhorn, the company's CFO and COO, will participate in the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026. Hirschhorn is scheduled to engage in a fireside chat at 3:10 p.m. ET, which will be available via audio webcast at investors.amwell.com.

Amwell specializes in offering a comprehensive, SaaS-based software platform that caters to both payers and health systems. This platform is designed to enhance patient access to more convenient, effective, and affordable care. By leveraging advanced technology, Amwell provides patients with a unified experience that allows for easy navigation across a range of clinical programs throughout the care continuum. This approach caters to the increasing demand for online healthcare services, ensuring that integrated, future-ready solutions are readily available.

The Amwell platform is notable for its scalability, having successfully facilitated care for millions of patients and their sponsors while achieving reliable outcomes. With nearly two decades in operation, Amwell has established itself as a trusted partner to some of the largest and most sophisticated healthcare organizations, both in the United States and globally.

Investors interested in learning more about Amwell’s latest developments and offerings can visit their official website or follow them on LinkedIn. For media inquiries, contact press@amwell.com, and for investor relations, reach out to Asher Dewhurst at amwell@icrhealthcare.com.

As we approach the TD Cowen 46th Annual Health Care Conference, Amwell® (NYSE: AMWL) presents an intriguing opportunity for investors in the healthcare technology sector. The participation of CFO and COO Mark Hirschhorn in a high-profile fireside chat signifies Amwell's commitment to engaging with stakeholders and underlines the company's robust position within the tech-enabled healthcare landscape.

Amwell offers a comprehensive SaaS-based platform designed to enhance healthcare delivery through technology. This platform caters not only to payers and health systems but also to millions of patients seeking enhanced access to care. In an era where telehealth adoption continues to grow, driven by patient demand for convenient and affordable healthcare solutions, Amwell's position as a leader is advantageous. The company's solutions are not only scalable but also integrate seamlessly with various clinical programs, highlighting their adaptability to evolving healthcare needs.

Investors should consider Amwell’s long-standing partnerships with prominent healthcare organizations, which strengthens its credibility and potential for continued growth. As the platform expands its features and partner network, it becomes increasingly poised to capture market share in the telehealth sector, which is projected to maintain a significant growth trajectory.

Additionally, attending investor conferences like the upcoming one in Boston helps position Amwell favorably by providing insights into its strategic direction and operational achievements. Given the increasing emphasis on digital health solutions, Amwell stands to benefit from its innovative approach to patient care.

In conclusion, investors looking for exposure to the healthcare technology market may find Amwell an attractive consideration, especially as the company continues to demonstrate its capabilities in transforming healthcare delivery through technology. Keep an eye on the developments from the conference for potential catalysts in the company's stock performance.